Laumas Sandeep's Form 4/A amendment
AmendedUnicycive Therapeutics, Inc. (UNCY) · filed Jul 28, 2026
- Accession no.
- 0001213900-26-082270
- Filed
- Jul 28, 2026, 4:15 PM ET
- Trade date
- May 14, 2026
- Filing delay
- 75 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- May 18, 2026
This filing lists 0 non-derivative transactions and 2 derivative transactions. It was filed 75 days after the trade.
This amendment replaces 0001213900-26-068920 (filed Jun 15, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Laumas SandeepCIK 0001721664 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 14, 2026 | Common Stock | AGrant or awardAcquired | +42,100 | $0.00 | $0 | 126,300 | Direct | |
| May 14, 2026 | Common Stock | AGrant or awardAcquired | +47,941 | $0.00 | $0 | 47,941 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.